scispace - formally typeset
D

D. Larenas-Linnemann

Researcher at Boston Children's Hospital

Publications -  15
Citations -  1730

D. Larenas-Linnemann is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Asthma & Allergen immunotherapy. The author has an hindex of 12, co-authored 15 publications receiving 1301 citations.

Papers
More filters
Journal ArticleDOI

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.

Torsten Zuberbier, +48 more
- 01 Jul 2018 - 
TL;DR: In this paper, an evidence-and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group.

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis)

Jean Bousquet, +261 more
TL;DR: The MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis) as discussed by the authors is a simple system centred around the patient which was devised to fill many of these gaps using Information and Communications Technology (ICT) tools and a clinical decision support system (CDSS) based on the most widely used guideline in allergy and its asthma comorbidity (ARIA 2015 revision).
Journal ArticleDOI

Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

Jean Bousquet, +541 more
TL;DR: The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status.
Journal ArticleDOI

Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper.

Jean Bousquet, +114 more
- 01 Oct 2010 - 
TL;DR: Development and implementation of guidelines in allergic rhinitis – an ARIA‐GA2LEN paper.
Journal ArticleDOI

Treatment of allergic rhinitis using mobile technology with real-world data: The MASK observational pilot study.

Jean Bousquet, +74 more
- 01 Sep 2018 - 
TL;DR: In a pilot study, this work attempted to provide additional and complementary insights on the real‐life treatment of allergic rhinitis (AR) using mobile technology.